Skip to main content
. 2024 Jul 23;25(7):270. doi: 10.31083/j.rcm2507270

Fig. 2.

Fig. 2.

ARNIs have potential beneficial molecular effects in HFpEF acting through different molecular mechanisms. ARNI, angiotensin receptor–neprilysin inhibitor; HFpEF, heart failure with preserved ejection fraction.